Tremfya: First Fully Under-the-Skin IL-23 Inhibitor Shot Approved for Ulcerative Colitis and ...
Mayo

Tremfya: First Fully Under-the-Skin IL-23 Inhibitor Shot Approved for Ulcerative Colitis and ...

1800 × 1200 px October 12, 2024 Peter Mayo

Tremfya: First Fully Under-the-Skin IL-23 Inhibitor Shot Approved for Ulcerative Colitis and ... is a high-quality image in the Mayo collection, available at 1800 × 1200 pixels resolution — ideal for both digital and print use.

Learn what Tremfya is used for in treating plaque psoriasis and psoriatic arthritis. Discover how this biologic medication works to manage your symptoms.

Image Details

TitleTremfya: First Fully Under-the-Skin IL-23 Inhibitor Shot Approved for Ulcerative Colitis and ...
Dimensions1800 × 1200 px
CategoryMayo
PublishedOctober 12, 2024
AuthorZeus
Downloads2,233
Views866

Read full article: What Is Tremfya Used For

// More Images